Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Blue Sky Uranium Expands Drill Plan to Advance the Ivana Uranium-Vanadium Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Schrodinger Inc SDGR

Technology Software - Application
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its... see more

Recent & Breaking News (NDAQ:SDGR)

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire April 18, 2024

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

Business Wire April 10, 2024

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

Business Wire March 20, 2024

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire March 19, 2024

Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results

Business Wire February 28, 2024

Schrödinger to Participate in Upcoming Investor Conferences

Business Wire February 20, 2024

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire February 16, 2024

Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28

Business Wire February 14, 2024

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire January 19, 2024

Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals

Business Wire January 8, 2024

Qiming Venture Partners' Portfolio Company UBTech Listed on Hong Kong Stock Exchange

PR Newswire December 29, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire December 19, 2023

Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event

Business Wire December 14, 2023

Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

Business Wire December 10, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire November 17, 2023

Schrödinger to Participate in Upcoming Investor Conferences

Business Wire November 6, 2023

Schrödinger to Present New Data for SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

Business Wire November 2, 2023

Schrödinger Reports Third Quarter 2023 Financial Results

Business Wire November 1, 2023

Schrödinger to Host Pipeline Day on December 14, 2023

Business Wire October 30, 2023

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire October 23, 2023